Showing posts with label Trump. Show all posts
Showing posts with label Trump. Show all posts

Wednesday, September 3, 2025

US Tariffs - Imagining the worst case

The US administration has imposed a 25% penal tariff on the goods imported from India, with few exceptions. The reason cited for this penal action is continued import of crude oil from Russia by the Indian refiners, despite the US administration insistence that sales proceeds from such oil sales are being used to finance the Russian war on Ukraine. These tariffs are over and above the MFN tariffs prevalent prior to 7th August 2025, and 25% reciprocal imposed with effect from 07th August.

Considering the exemption for several items that are critical for the US supply chains, e.g., mobile phones, certain metal items, pharma, semiconductors, energy etc., the effective tariff rates on Indian exports to the US are estimated to be ~33%.

India has termed this penal action “unfair, unjustified, unreasonable”. The public stance of the Indian government is that buying Russian oil is critical for our energy security, and it is our prerogative to decide from where to buy. 

Considering the current seemingly inflexible stance of both the parties on this issue, it would not be unreasonable to assume that these penal tariffs may stay, at least for a few more months, till a breakthrough in trade talks is achieved. Reportedly, the Indo-US bilateral trade talks are continuing and the negotiators are hopeful that a bilateral trade agreement (BTA) may be achieved in the next few months.

However, assuming the worst case (penal tariffs stay for a longer term than presently estimated), the repercussions could be serious for the Indian economy, in general, and exporters in particular. Some of the consequences of sustained penal tariffs could be listed as follows. Please note that these are based on worst case assumptions and not a base case.

Capital and jobs drain: If the penal tariffs sustain, a large number of SMEs, catering mostly to the US demand, especially in sectors like textile, jewelry, carpet, could think of relocating their manufacturing base (fully or partially) to a more tariff friendly jurisdiction like UAE, Oman, Egypt etc. This would result in material capital outflow and loss of jobs for local workers.

Job losses and labor migration: The loss of business due to lower exports to the US is likely to affect the labor-intensive SME sector the most. Various estimates are suggesting a loss of over one million manufacturing jobs directly. There could be material secondary job losses also as exporters scale down their businesses and workers migrate to their native places. This could adversely impact the already struggling private consumption growth and household savings.

Capital controls: India has traditionally run a trade surplus with the US. Loss of exports to the US market, may erode this surplus, adversely impacting the overall trade balance of India. To manage this widening of trade deficit, the government might consider, like it did in the 2013 BoP crisis, imposing some capital controls like reducing limits under LRS remittance, capital investments (outbound FDI) through automatic route, etc. It may also consider liberalizing rules for FDI in sectors like retail trade, increasing competition for the local businesses.

Uncertainty over pharma and services: As of now, pharmaceuticals and services are not covered by the reciprocal and penal tariffs. These two together form ~45% of total Indian exports to the US. If the two sides are unable to find a solution to the current impasse, the US may consider imposing some tariff or non-tariff barriers on pharma and services also. Though not on the board this morning, in the back of minds it must be bothering many entrepreneurs and investors. Even the global corporations making large investments in setting up GCCs in India, would be mindful of this risk and slowdown their future investment plans.

India+1: Presently, it may not be viable for a lot of American importers to immediately replace Indian imports with other countries. However, to mitigate a long-term risk, American importers might explore developing vendors in other countries, even if it costs a fraction higher. This clouds the long-term prospects of export growth for the Indian vendors, even if the present tariff impasse gets resolved in the next few months.

Wider sanctions: To increase pressure on India, the US administration may enhance the scope of penal tariffs to non-tariff restrictions (effectively sanctions like 1998) to include sale of critical defense components, and technology transfer agreements etc. This may adversely impact, for example, the plans to develop local fighter jets and develop a local semiconductor ecosystem.

Remittances: Sanctions and/or fear of sanctions can materially affect remittances from the US to India. On the positive side, many NRIs can accelerate their remittances to preempt remittance tax, restrictions on remittances to India or freezing of assets on some convoluted pretext (This has already happened with Russians and Iranians). On the negative side, VISA restrictions, cancellation of Green cards and H1Bs etc., may impact remittances adversely to some extent.

Uncertainty for tech workers and students: For the past many years, India has sent the largest number of tech workers and students to the US. Escalation in trade conflict could impact this trend adversely. Moreover, dark clouds of uncertainty may engulf the workers and students already present in the US or planning to travel to the US in near term. There are already reports of several Indian students (present and prospective) suffering from extreme stress and depression.

Rise in Chinese threat: To mitigate the impact of the US tariffs and potential sanctions, the Indian government has already enhanced its engagement with the Chinese government and businesses. Reportedly, India has shown inclination to relax several restrictions on the Chinese businesses, capital and products. This is in spite of the past history of mistrust and deceit, and recent Chinese participation (against India) in Operation Sindoor. A liberal access to the Chinese capital and technology might seriously compromise the security of the country; and potentially create a gulf between the government and defense establishment.

I am definitely not suggesting that the government of India should accede to the unfair and unjust US demands and sign an unfavorable trade agreement. I have just listed some pointers for adjusting investment strategy, should things take a turn for the worst.

Thursday, August 21, 2025

A visit to the street

2025 is proving to be an interesting year for traders in the Indian stocks. The traders have faced multiple challenges in the past eight months; and had some good opportunities to make extraordinary profit. More notably—

Thursday, August 14, 2025

Strategy review in light of the US tariffs - 3

 …continuing from yesterday.

Wednesday, August 13, 2025

Strategy review in light of the US tariffs - 2

…continuing from yesterday.

Tuesday, August 12, 2025

Strategy review in light of the US tariffs

Thursday, August 7, 2025

MPC saves one for the external shock

The Monetary Policy Committee (MPC) of the Reserve Bank of India concluded its three-day meeting on Wednesday. The committee voted unanimously to keep the policy repo rate unchanged at 5.50 per cent. The MPC also decided to continue with the neutral monetary policy stance.

Thursday, July 31, 2025

Powell refuses to toe the Trump line, India stay guarded

 The Federal Open Market Committee (FOMC) of the US Federal Reserve (Fed) maintained its policy rates at 4.25% to 4.5% range, by a majority vote. It was the first occasion since 1993 when two Fed governors voted against the majority decision. Fed governors, Michelle Bowman and Christopher Waller, wanted a 25bps rate cut at the meeting, concluded on Wednesday.

Thursday, July 24, 2025

Two random thoughts

Antimicrobial resistance becoming ominous

Antimicrobial resistance (AMR) is fast emerging as one of the most ominous health concerns at global level.

As per the World Health Organization (WHO), “Antimicrobials – including antibiotics, antivirals, antifungals, and antiparasitic – are medicines used to prevent and treat infectious diseases in humans, animals and plants. Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites no longer respond to antimicrobial medicines. As a result of drug resistance, antibiotics and other antimicrobial medicines become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness, disability and death.

AMR is a natural process that happens over time through genetic changes in pathogens. Its emergence and spread are accelerated by human activity, mainly the misuse and overuse of antimicrobials to treat, prevent or control infections in humans, animals and plants.

Antimicrobial medicines are the cornerstone of modern medicine. The emergence and spread of drug-resistant pathogens threaten our ability to treat common infections and to perform life-saving procedures including cancer chemotherapy and caesarean section, hip replacements, organ transplantation and other surgeries.

In addition, drug-resistant infections impact the health of animals and plants, reduce productivity in farms, and threaten food security.”

Please note that AMR is not a future threat. It is unfolding now—insidiously, incrementally, and globally.

Wolf may enter the barn unnoticed

There’s another kind of resistance building—this time in global financial markets.

President Trump is seeking to alter the global terms of trade through tariffs. In a massive exercise his administration is undertaking a review of the US’s trade terms with all countries (except perhaps Russia and North Korea), regardless of the size of their economy and quantum of trade with the US.

Initially, the global markets were reacting with a good deal of volatility to each tariff related announcement coming out of the White House. The Trump administration would take note of such volatility and take a step back. Of late, something has changed - Markets have "priced in" chaos. Markets are becoming immune to such announcements, assuming the proposed tariffs will not be implemented, as has been the case previously. Taking advantage of this market complacency, the US administration has already implemented some tariff proposals, including a 50% tariff on copper imports into the US. Trade deals have been reportedly signed with key trade partners like UK, China, Vietnam, Japan, Indonesia, and Philippines, materially altering the US’s terms of trade with these countries.

It's a classic “boy who cried wolf” dynamic playing out. Markets are becoming resistant to all threatening news, be it trade, geopolitics or climate.

The question to be examined is whether this resistance is materially different from AMR; or it is similar and would eventually weaken the resilience of markets, making them susceptible to sudden collapses?

As of this morning, I have no view on markets susceptibility to sudden collapses, but I do believe that mindless use of Antimicrobial in India (both through prescription and self-medication) is fast assuming epidemic proportions, and could have catastrophic consequences.

Tuesday, July 15, 2025

A method in madness

It is a common adage amongst the financial market participants that “When America sneezes, the rest of the world catches a cold”. The origin of this belief is the global market turbulence in the aftermath of 1929 Wall Street crash. In the past 100 years, whenever the US economy or markets have faced any serious problem, most of the global economies and markets have witnessed elevated volatility and erosion in asset prices. The prime reason for this correlation of the US economy and markets has been the disproportionately large size of the US economy and markets; dominance of the US dollar in global trade; and over-reliance of emerging markets on the US for investment, development assistance and humanitarian aid.

In the past couple of years, serious concerns have emerged about the sustainability of the US public debt and fiscal deficit. The overall GDP growth has been aligned to the average of the post global financial crisis (GFC) period. The efforts to accelerate growth have not yielded much results.

Since January 2025, when the incumbent President (Mr. Trump) assumed charge, things have been rather volatile. Mr. Trump has presented some radical ideas to tackle the economic problems distressing the US economy. These ideas include renegotiating terms of trade with all the trade partners; drastically reducing the budget for global development assistance and humanitarian aid programs; optimizing the size of US administration; and reducing the US commitment to strategic alliance (e.g., NATO); multilateral institutions including the UN and IMF etc.

The impact of these measures, whenever these are effectively implemented (or abandoned), may be felt in the US economy and markets, as well as the global economy and markets. Till then expect the markets to remain tentative and sideways.

Trump Plan

Notwithstanding the theatrics of Mr. Trump, a method in his madness is conspicuous. As I see it, the primary problem of the US is its unsustainable debt. At last count the US public debt was out US$36trn (appx 123% of its GDP), entailing over US$1trn in annual interest payments.

The conventional way to reduce this debt is to use a judicious mix of —

(i)    Curtailing government expenses;

(ii)   Increasing revenue;

(iii)  Inflating the economy to reduce the value of money

(iv)  Weakening the currency; and

(v)   Lowering the debt servicing cost through lower rates.

Mr. Trump is trying to achieve through tariffs (higher revenue and inflation); lower expenses (reducing the size of government, cutting foreign aid, lower clean energy subsidies, etc.); additional revenue (higher VISA fee, new taxes etc.); weaker USD; and coaxing the Fed to cut rates.

How much success he gets in his endeavor, we will know in the next 6-12 months. For now, I see nothing to worry about whatever is emanating from the US. In the next 12 months, the situation will either be the same or significantly better. I shall stay hopeful, though.